The minister clarified the government's position on Zumba dance, a high-energy fitness programme introduced in schools in Kerala by the General Education Department as part of its anti-drug campaign, facing opposition from certain Muslim groups who argue that it went against moral values.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.
Pharma firms will have to affix barcodes on consignments of all tertiary level packaging, such as cartons, following a government order.
The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.
According to a statement issued by the Grand Mufti's office, the decision was made after a high-level meeting held in Yemen's capital, Sanaa, where it was decided to completely cancel the death sentence, which had been temporarily suspended earlier.
India is seeking either an exemption or a longer timeline on the pharmaceutical tariffs, expected to kick in by July 31.
Majithia and his wife claimed that members of the Vigilance Bureau barged into their house in Green Avenue in Amritsar. They claimed that a similar raid was conducted at their residence in Chandigarh.
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.
Indian non-profit 'Educate Girls' wins the Ramon Magsaysay Award for its work in educating out-of-school girls in remote villages. The award recognizes selfless service to the peoples of Asia.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
Small scale drug makers fear that they may have to shell out anything between Rs 20 lakh (Rs 2 million) to Rs 1 crore (Rs 10 million) for acquiring land and equipment as mandated by the new GLP.
Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.
Pharmaceutical majors like Ranbaxy, Dr Reddy's Lab, Wockhardt, Glenmark and Sun Pharma are now treading a careful patent litigation path in the US market to expand their generic business instead of the aggressive patent challenges they pursued until a few years ago.
India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic generic drugs industry, an official said. During the negotiations, the UK had asked to include this provision in the trade pact.
The stock and bond markets told Trump firmly that any idea of isolating China would lead to harming the US economy and this forced Trump to backtrack, points out Aakar Patel.
Unlike India, the US is a free-pricing market.
A Nasdaq-listed Israeli drug company has entered into an agreement with India's JB Chemicals and Pharmaceuticals to jointly develop products to improve its competitive edge in the US and other world markets.
India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion document on the issues to the US.
Pharma major, Dr Reddy's Laboratories Ltd on Wednesday said it will form an integrated drug development company 'Perlecan Pharma Pvt Ltd' with an equity capital of $52.5 million from two venture capital investors.
Orchid Chemicals and Pharmaceuticals is acquiring a Chennai-based firm for Rs 260 million ($5.4 million) in an all-cash deal to expand to speciality drugs, the Bombay Stock Exchange said on Tuesday.
'What India has done will surely embolden more countries to stand up to Trump.'
Indian drug makers may lose out on outsourcing contracts as overseas pharmaceutical companies defer their visits to the country in the wake of Mumbai terror attacks, according to industry experts.
The less-than-anticipated results of a few big-ticket acquisitions made in the previous year earlier also acted as a dampener. Piramal Healthcare, Biocon and other drug makers spent about Rs 1,800 crore (Rs 18 billion) in 2008 for acquiring assets abroad, compared to more than Rs 5,500 crore (Rs 55 billion) spent in 2007 in 14 such major deals, according to Business Standard data.
Industry associations and companies in the United States, including the US Chamber of Commerce, Coalition of Services Industries and the iconic bike company Harley Davidson have called on the Donald Trump dispensation to push India to reduce tariffs, non-tariffs, and regulatory barriers to boost American exports.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances